Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 42Precursor Cell Lymphoblastic Leukemia-Lymphoma 33Lymphoma, Large B-Cell, Diffuse 29Lymphoma, Follicular 15Lymphoma, Non-Hodgkin 13Leukemia 11Hodgkin Disease 11Burkitt Lymphoma 10Leukemia, Biphenotypic, Acute 7Recurrence 6Lymphoma, Large-Cell, Anaplastic 6Lymphoma, B-Cell 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Immunoblastic Lymphadenopathy 4Dendritic Cell Sarcoma, Interdigitating 4Neoplasms 3Lymphoma, T-Cell, Peripheral 3Lymphoma, T-Cell 3Lymphoma, Mantle-Cell 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, B-Cell, Marginal Zone 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Neurotoxicity Syndromes 2Neoplasm, Residual 2Leukemia, Lymphocytic, Chronic, B-Cell 2Enteropathy-Associated T-Cell Lymphoma 2Down Syndrome 2Vomiting 1Pulmonary Disease, Chronic Obstructive 1Philadelphia Chromosome 1

Interventions

Aprepitant 7Ondansetron 5Palonosetron 3Granisetron 3Dexamethasone 3Cyclophosphamide 3Calcium Dobesilate 3Vincristine 2Rituximab 2Doxorubicin 2dexamethasone acetate 1dexamethasone 21-phosphate 1Yoga 1Tropisetron 1Sugars 1R-CHOP protocol 1Prochlorperazine 1Prednisone 1Prednisolone 1Music Therapy 1Metoclopramide 1Lorazepam 1Immunoenzyme Techniques 1Electroacupuncture 1Cyproheptadine 1Antiemetics 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Nausea × Prednisolone × Lymphoid × Clear all
NCT01843868 2024-08-07

Emesis Control Study in Non-Hodgkin Lymphoma Patients Receiving R-CHOP

Australasian Leukaemia and Lymphoma Group

Phase NA Withdrawn
Lymphoid

Lymphoma, Lymphoma, Non-Hodgkin, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡